Related Experiment Video
Updated: Aug 8, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
Early growth response 1 protein, an upstream gatekeeper of the p53 tumor suppressor, controls replicative senescence
Anja Krones-Herzig1, Eileen Adamson, Dan Mercola
1Sidney Kimmel Cancer Center, San Diego, CA 92121, USA.
Abstract:
The proliferation of most primary cells in culture is limited by replicative senescence and crisis, p53-dependent events. However, the regulation of p53 itself has not been defined. We find that deletion of the early growth response 1 (EGR1) transcription factor leads to a striking phenotype, including complete bypass of senescence and apparent immortal growth consistent with loss of a suppressor gene. EGR1-null mouse embryo fibroblasts (MEFs) exhibit decreased expression of p53, p21(Cip1/Waf1), and other p53 "marker" proteins. Precrisis WT but not EGR1-null cells exhibit irradiation-induced arrest. WT MEFs that emerge from crisis exhibit a mutated p53 (sequence confirmed), colony formation, and tumorigenicity. In contrast, high-passage EGR1-null MEFs retain the WT p53 sequence but with much reduced expression, remain untransformed, and grow continuously. An EGR1-expressing retrovirus restores p53 expression and sencescence to EGR1-null but not p53-null MEFs or postcrisis WT cells. Taken together, the results establish EGR1 as a major regulator of cell senescence and previously undescribed upstream "gatekeeper" of the p53 tumor suppressor pathway.
Insights
Early growth response 1 (EGR1) acts as a crucial gatekeeper for the p53 tumor suppressor pathway, regulating cell senescence. Its absence allows cells to bypass senescence and achieve immortal growth, highlighting EGR1
Area of Science:
- Cellular senescence
- Tumor suppressor pathways
- Molecular biology
Background:
- Cell proliferation is typically limited by replicative senescence and crisis, processes dependent on the p53 protein.
- The upstream regulators controlling p53's function, particularly in senescence, remain largely undefined.
- Understanding these regulatory mechanisms is critical for comprehending tumor suppression and cellular aging.
Purpose of the Study:
- To investigate the role of the early growth response 1 (EGR1) transcription factor in regulating cellular senescence and the p53 pathway.
- To determine if EGR1 functions as a suppressor of cellular immortalization.
- To elucidate the relationship between EGR1, p53, and the onset of replicative senescence.
Main Methods:
- Generation and characterization of EGR1-null mouse embryo fibroblasts (MEFs).
- Analysis of p53 expression, p53 target genes (e.g., p21Cip1/Waf1), and cell cycle arrest.
- Assessment of senescence bypass, immortal growth, and tumorigenicity in EGR1-deficient cells.
- Complementation assays using retroviral expression of EGR1 in EGR1-null and wild-type (WT) MEFs.
Main Results:
- EGR1-null MEFs exhibited a complete bypass of senescence and demonstrated immortal growth potential.
- EGR1 deficiency led to significantly decreased expression of p53 and p21(Cip1/Waf1) proteins.
- While wild-type MEFs entering crisis developed mutated p53 and became tumorigenic, EGR1-null MEFs maintained wild-type p53 sequence with reduced expression and remained untransformed.
- Restoration of EGR1 expression in EGR1-null cells re-established p53 expression and induced senescence.
Conclusions:
- Early growth response 1 (EGR1) is a critical regulator of cellular senescence.
- EGR1 acts as an upstream gatekeeper for the p53 tumor suppressor pathway, controlling its expression and function.
- Loss of EGR1 function contributes to cellular immortalization by impairing the p53-dependent senescence response.
Related Concept Videos
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage Can Stall the Cell Cycle

